2022
Physical Performance and Non-Esterified Fatty Acids in Men and Women after Transcatheter Aortic Valve Implantation (TAVI).
Härdrich M, Haase-Fielitz A, Fielitz J, Boschmann M, Pivovarova-Ramich O, Pfeiffer AFH, Rudovich N, Weylandt KH, Butter C.
Nutrients. 2022 Jan 2;14(1):203. doi: 10.3390/nu14010203.
Incidence and risk factors for acute kidney injury in patients with cardiac implantable electronic devices undergoing transvenous lead removal.
Edlinger C, Bannehr M, Haj-Kheder S, Möller V, Georgi C, Reiners D, Dworok V, Haase-Fielitz A, Butter C.
Clin Nephrol. 2022 Jan 24. doi: 10.5414/CN110723.
2021
Basic resuscitation skills of medical students - a monocenter randomized simulation trial.
Bülow C, Krispin SK, Lehmanski F, Spalding G, Haase-Fielitz A, Butter C, Nübel J.
GMS J Med Educ. 2021 Nov 15;38(7):Doc116. doi: 10.3205/zma001512. eCollection 2021.
PMID: 34957321 Free PMC article. Clinical Trial.
Prognostic Implications of a Novel Algorithm to Grade Secondary Tricuspid Regurgitation.
Bannehr M, Kücken T, Ulrike K, Haase-Fielitz A, Butter C.
J Am Soc Echocardiogr. 2021 Dec;34(12):1316-1317. doi: 10.1016/j.echo.2021.08.014. Epub 2021 Aug 27.
PMID: 34461248
Right Ventricular Longitudinal Strain Predicts Survival in Patients With Functional Tricuspid Regurgitation.
Bannehr M, Kahn U, Liebchen J, Okamoto M, Hähnel V, Georgi C, Dworok V, Edlinger C, Lichtenauer M, Kücken T, Kropf S, Haase-Fielitz A, Butter C.
Can J Cardiol. 2021 Jul;37(7):1086-1093
2020
The Impact of Commonly-Worn Face Masks on Physiological Parameters and on Discomfort During Standard Work-Related Physical Effort.
Georgi C, Haase-Fielitz A, Meretz D, Gäsert L, Butter C.
Dtsch Arztebl Int. 2020 Oct 2;117(40):674-675. doi: 10.3238/arztebl.2020.0674
2019
Kalbacher D., Schäfer U., V Bardeleben R.S., Eggebrecht H., Sievert H., Nickenig G., Butter C., May A.E., Bekeredjian R., Ouarrak T., Kuck K.H., Plicht B., Zahn R., Baldus S., Ince H., Schillinger W., Boekstegers P., Senges J., Lubos E.(2019) Long-term outcome, survival and predictors of mortality after MitraClip therapy: Results from the German Transcatheter Mitral Valve Interventions (TRAMI) registry.
Kuschyk J., Nägele H., Heinz-Kuck K., Butter C., Lawo T., Wietholt D., Roeger S., Gutterman D., Burkhoff D., Rousso B., Borggrefe M.(2019) Cardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT).
2018
Albert C., Albert A., Bellomo R., Kropf S., Devarajan P., Westphal S., Baraki H., Kutschka I., Butter C., Haase M., Haase-Fielitz A.(2018) Urinary neutrophil gelatinase-associated lipocalin-guided risk assessment for major adverse kidney events after open-heart surgery.
Butter C., Groß J., Haase-Fielitz A., Sims H., Deutsch C., Bramlage P., Neuss M.(2018) Impact of Rehabilitation on Outcomes after TAVI: A Preliminary Study.
Gilgen N., Farah A., Scheller B., Ohlow M.A., Mangner N., Weilenmann D., Wöhrle J., Jamshidi P., Leibundgut G., Möbius-Winkler S., Zweiker R., Krackhardt F., Butter C., Bruch L., Kaiser C., Hoffmann A., Rickenbacher P., Mueller C., Stephan F.P., Coslovsky M., Jeger R., BASKET-SMALL 2 Investigators(2018) Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2.
Halbach M., Abraham W.T., Butter C., Ducharme A., Klug D., Little W.C., Reuter H., Schafer J.E., Senni M., Swarup V., Wachter R., Weaver F.A., Wilks S.J., Zile M.R., Müller-Ehmsen J.(2018) Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.
Jabbour R.J., Tanaka A., Finkelstein A., Mack M., Tamburino C., Van Mieghem N., de Backer O., Testa L., Gatto P., Purita P., Rahhab Z., Veulemans V., Stundl A., Barbanti M., Nerla R., Sinning J.M., Dvir D., Tarantini G., Szerlip M., Scholtz W., Scholtz S., Tchetche D., Castriota F., Butter C., Søndergaard L., Abdel-Wahab M., Sievert H., Alfieri O., Webb J., Rodés-Cabau J., Colombo A., Latib A.(2018)
Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement.
Jeger R.V., Farah A., Ohlow M.A., Mangner N., Möbius-Winkler S., Leibundgut G., Weilenmann D., Wöhrle J., Richter S., Schreiber M., Mahfoud F., Linke A., Stephan F.P., Mueller C., Rickenbacher P., Coslovsky M., Gilgen N., Osswald S., Kaiser C., Scheller B., BASKET-SMALL 2 Investigators(2018) Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet, 392 (10150): 849-856
Kaneko H., Hoelschermann F., Seifert M., Tambor G., Okamoto M., Moeller V., Neuss M., Butter C.(2018) Predictors of permanent pacemaker implantation after transcatheter aortic valve implantation for aortic stenosis using Medtronic new generation self-expanding CoreValve Evolut R. Heart Vessels
Kaneko H., Kitamura M., Neuss M., Okamoto M., Schmidt T., Alessandrini H., Kuck K.H., Komuro I., Frerker C., Butter C.(2018) MitraClip in Patients With Mitral Regurgitation and Left Ventricular Ejection Fraction <30% - Potential Implications for the Treatment of Patients in Japan.
Kaneko H., Neuss M., Okamoto M., Weissenborn J., Butter C.(2018) Impact of Preprocedural Anemia on Outcomes ofPatients With Mitral Regurgitation Who UnderwentMitraClip Implantation.
Koehler F., Koehler K., Deckwart O., Prescher S., Wegscheider K., Kirwan B.A., Winkler S., Vettorazzi E., Bruch L., Oeff M., Zugck C.,
Doerr G., Naegele H., Störk S., Butter C., Sechtem U., Angermann C., Gola G., Prondzinsky R., Edelmann F., Spethmann S., Schellong S.M., Schulze P.C., Bauersachs J., Wellge B., Schoebel C., Tajsic M., Dreger H., Anker S.D., Stangl K.(2018) Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial.
Linke A., Holzhey D., Möllmann H., Manoharan G., Schäfer U., Frerker C., Worthley S.G., van Boven A.J., Redwood S., Kovac J., Butter C., Søndergaard L., Lauten A., Schymik G., Walther T.(2018) Treatment of Aortic Stenosis With a Self-Expanding, Resheathable Transcatheter Valve: One-Year Results of the International Multicenter Portico Transcatheter Aortic Valve Implantation System Study.
Seifert M., Moeller V., Arya A., Schau T., Hoelschermann F., Butter C.(2018) Prognosis associated with redo cardiac resynchronization therapy following complete device and lead extraction due to device-related infection.
